rs6982971

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000037.4(ANK1):​c.450A>G​(p.Val150Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0533 in 1,613,518 control chromosomes in the GnomAD database, including 2,644 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 174 hom., cov: 32)
Exomes 𝑓: 0.054 ( 2470 hom. )

Consequence

ANK1
NM_000037.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.38

Publications

6 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • hereditary spherocytosis type 1
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 8-41725923-T-C is Benign according to our data. Variant chr8-41725923-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261313.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.38 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0541 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000037.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
NM_000037.4
MANE Select
c.450A>Gp.Val150Val
synonymous
Exon 6 of 43NP_000028.3
ANK1
NM_001142446.2
c.549A>Gp.Val183Val
synonymous
Exon 6 of 43NP_001135918.1P16157-21
ANK1
NM_020476.3
c.450A>Gp.Val150Val
synonymous
Exon 6 of 42NP_065209.2P16157-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
ENST00000289734.13
TSL:1 MANE Select
c.450A>Gp.Val150Val
synonymous
Exon 6 of 43ENSP00000289734.8P16157-3
ANK1
ENST00000265709.14
TSL:1
c.549A>Gp.Val183Val
synonymous
Exon 6 of 43ENSP00000265709.8P16157-21
ANK1
ENST00000347528.8
TSL:1
c.450A>Gp.Val150Val
synonymous
Exon 6 of 42ENSP00000339620.4P16157-1

Frequencies

GnomAD3 genomes
AF:
0.0430
AC:
6553
AN:
152242
Hom.:
172
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0255
Gnomad AMI
AF:
0.0603
Gnomad AMR
AF:
0.0405
Gnomad ASJ
AF:
0.0268
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.00993
Gnomad FIN
AF:
0.0766
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0556
Gnomad OTH
AF:
0.0339
GnomAD2 exomes
AF:
0.0461
AC:
11400
AN:
247026
AF XY:
0.0433
show subpopulations
Gnomad AFR exome
AF:
0.0250
Gnomad AMR exome
AF:
0.0703
Gnomad ASJ exome
AF:
0.0257
Gnomad EAS exome
AF:
0.00120
Gnomad FIN exome
AF:
0.0766
Gnomad NFE exome
AF:
0.0542
Gnomad OTH exome
AF:
0.0440
GnomAD4 exome
AF:
0.0544
AC:
79425
AN:
1461158
Hom.:
2470
Cov.:
34
AF XY:
0.0525
AC XY:
38132
AN XY:
726862
show subpopulations
African (AFR)
AF:
0.0265
AC:
886
AN:
33470
American (AMR)
AF:
0.0678
AC:
3032
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.0266
AC:
694
AN:
26134
East Asian (EAS)
AF:
0.00118
AC:
47
AN:
39694
South Asian (SAS)
AF:
0.0150
AC:
1294
AN:
86204
European-Finnish (FIN)
AF:
0.0716
AC:
3809
AN:
53186
Middle Eastern (MID)
AF:
0.0131
AC:
73
AN:
5552
European-Non Finnish (NFE)
AF:
0.0600
AC:
66710
AN:
1111864
Other (OTH)
AF:
0.0477
AC:
2880
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
4617
9233
13850
18466
23083
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2558
5116
7674
10232
12790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0431
AC:
6566
AN:
152360
Hom.:
174
Cov.:
32
AF XY:
0.0423
AC XY:
3150
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.0256
AC:
1065
AN:
41596
American (AMR)
AF:
0.0405
AC:
620
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.0268
AC:
93
AN:
3468
East Asian (EAS)
AF:
0.000772
AC:
4
AN:
5180
South Asian (SAS)
AF:
0.00993
AC:
48
AN:
4832
European-Finnish (FIN)
AF:
0.0766
AC:
814
AN:
10622
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0556
AC:
3781
AN:
68026
Other (OTH)
AF:
0.0369
AC:
78
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
316
632
947
1263
1579
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0490
Hom.:
139
Bravo
AF:
0.0406
Asia WGS
AF:
0.0190
AC:
68
AN:
3478
EpiCase
AF:
0.0467
EpiControl
AF:
0.0520

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Hereditary spherocytosis type 1 (3)
-
-
3
not provided (3)
-
-
1
not specified (1)
-
-
1
Spherocytosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
12
DANN
Benign
0.65
PhyloP100
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6982971; hg19: chr8-41583441; COSMIC: COSV55897007; API